You've reached the limit for free Overall Ranking scores. For more information, request a demo.
See CSRHub in Action
You have a total of 10 free searches available.
| Low 0-29 | 30-39 | 40-49 | 50-59 | 60-79 | 80-100 High |
Founded in May 1991, Myriad Genetics is a biotechnology company engaged in molecular diagnostics and focused on understanding the role of genes in human disease and then use that information to develop and commercialize products that assess a person's risk of developing disease later in life and guide treatment decisions based on an individual's genetic makeup and specific cause of disease. The company has launched seven commercial molecular diagnostic products, which it markets through a 250-person sales force in the United States.
| Ticker: | MYGN |
| ISIN: | US62855J1043 |
| Address: |
320 Wakara Way |
| Salt Lake City, UT, 84108, USA | |
| Website: | Myriad Genetics, Inc. |
| Phone #: | 801-584-3600 |
| ESG Web Area: | Subscribers Only ? |
| Industry: | Biotechnology |
We considered many names for our site—in fact we spent our first year and a half under a different name—EkoHub. We liked “Eko” — coming from the Greek word Oikos, related to economy, ecology, and “home” or social concerns. From the beginning, we believed the word “Hub” reflected our desire to be at the center of the sustainability area, providing knowledge, harmony, and consensus among the hundreds of experts judging the ESG performance of companies.